Kiadis Pharma appoints Stefaan Allemeersch as Vice President Business Development
Jun 18th 2009
Amsterdam, 17 June, 2009 – Biopharmaceutical company Kiadis Pharma, focusing on the development of innovative cell based therapeutics in the field of...
read more 
(NL version)
(NL version)
Kiadis Pharma reports ATIR™ clinical data, further supporting its potential in mismatched bone marrow transplantations - ATIR™ data presented at the annual EBMT Presidential Symposium
Apr 8th 2009
Biopharmaceutical company Kiadis Pharma reported preliminary clinical data on ATIR™ showing its potential in mismatched bone marrow transplantations....
read more (NL version)
(NL version)
- Kiadis Pharma appoints Dr. Gerben van ‘t Klooster as Chief Operations Officer - Mar 11th 2009 (NL)
- Kiadis Pharma’s lead investigator presents results ATIR™ clinical trial at the BMT tandem meeting - Feb 6th 2009 (NL)
- Kiadis Pharma appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer - Jan 6th 2009 (NL)
- Kiadis Pharma announces appointment of Mark Skaletsky to its Supervisory Board - Dec 11th 2008 (NL)
- Kiadis Pharma receives two orphan drug designations for Reviroc™ from the FDA - Dec 8th 2008 (NL)
1096 EG Amsterdam
The Netherlands
t +31 (0)20 314 02 50
f +31 (0)20 314 02 51